{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:02:01Z","timestamp":1784523721482,"version":"3.55.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Psilocybin-assisted therapy is continuing to show significant positive effects for palliative cancer patients, both in reducing symptoms and improving one\u2019s sense of hope and meaning. Most research has focused on individual therapy models, limiting access and overlooking potential community-based benefits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This qualitative study describes the results of patients experiencing distress related to a terminal health condition who enrolled in six to eight once-weekly group resilience-based community of practice (CoP) sessions combined with one psilocybin-assisted therapy (PaT) session. This virtual hybrid group therapy model is research informed, with a curriculum that provides knowledge-based content, combined with the relational elements necessary to successfully deliver group-administered psilocybin-assisted therapy. Patients were interviewed using semi-structured question list and transcripts were coded and themes captured in an iterative manner. The CoP sequence included preparation meetings before the in-person medicine session and integration meetings afterward, allowing the group relationship and safety practices to be established before dosing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirty-one PaT sessions were provided for 25 participants within four iterative cohorts over the span of 1\u202fyear (November 2021\u2013November 2022). Completion rates were high (84%), with participants reporting enhanced trust in self, improved outlook on life, and strengthened connection to community. Peer support, relational safety, and regulation practices were central to outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrates the feasibility, safety, and psychosocial benefits of group-administered PaT supported by virtual CoPs, providing a scalable, cost-effective model for public health interventions in end-of-life care. Its novelty lies in combining group therapy, hybrid delivery, and resilience-based curriculum to expand access and enhance community support for a vulnerable population. Participants\u2019 mixed feedback also suggests that hybrid group PaT may offer distinctive benefits of peer witnessing and community continuity while requiring careful attention to individual preference, room logistics, and sensory control during group dosing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1767215","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T04:20:36Z","timestamp":1784521236000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Vivian WL","family":"Tsang","sequence":"first","affiliation":[{"name":"Department of Continuing Education, Evidence Based Health Care, University of Oxford","place":["Oxford, United Kingdom"]},{"name":"Department of Psychiatry, Faculty of Medicine, University of British Columbia","place":["Vancouver, BC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Kryskow","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Faculty of Medicine, University of British Columbia","place":["Vancouver, BC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crosbie","family":"Watler","sequence":"additional","affiliation":[{"name":"Island Health Services","place":["Nanaimo, BC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearl","family":"Allard","sequence":"additional","affiliation":[{"name":"Department of Health and Human Services, Vancouver Island University","place":["Nanaimo, BC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Dames","sequence":"additional","affiliation":[{"name":"Department of Health and Human Services, Vancouver Island University","place":["Nanaimo, BC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","article-title":"Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies","volume":"12","author":"Mitchell","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0022-3999(00)00080-5","article-title":"Anxiety and depression in cancer patients: relation between the hospital anxiety and depression scale and the European Organization for Research and treatment of cancer core quality of life questionnaire","volume":"49","author":"Skarstein","year":"2000","journal-title":"J Psychosom Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3109\/09540261.2013.842542","article-title":"Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review","volume":"26","author":"Grassi","year":"2014","journal-title":"Int Rev Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"CD011006","DOI":"10.1002\/14651858.CD011006.pub3","article-title":"Antidepressants for the treatment of depression in people with cancer","volume":"2018","author":"Ostuzzi","year":"2018","journal-title":"Cochrane Libr"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0269881119897615","article-title":"Long term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer","volume":"34","author":"Agin-Liebes","year":"2020","journal-title":"J Psychopharmacol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized control trial","volume":"30","author":"Ross","year":"2016","journal-title":"J Psychopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1021\/acsptsci.1c00020","article-title":"Acute and sustained reductions in loss of meaning and suicidal ideation following psilocybin-assisted psychotherapy for psychiatric and existential distress in life-threatening cancer","volume":"4","author":"Ross","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J Psychopharmacol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.3390\/molecules26102948","article-title":"The therapeutic potential of psilocybin","volume":"26","author":"Lowe","year":"2021","journal-title":"Molecules"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuropharm.2018.05.012","article-title":"The abuse potential of medical psilocybin according to the 8 factors of the controlled substances act","volume":"142","author":"Johnson","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","article-title":"Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents","volume":"35","author":"Glennon","year":"1984","journal-title":"Life Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Front Hum Neurosci"},{"key":"ref13","first-page":"10","volume-title":"Psilocybin Mushrooms of the World","author":"Stamets","year":"1996"},{"key":"ref14","volume-title":"Plants of the Gods: Their Sacred, Healing, and Hallucinogenic Powers","author":"Schultes","year":"2001"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eclinm.2020.100538","article-title":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study","volume":"27","author":"Anderson","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1177\/00221678211022949","article-title":"Participant reports of mindfulness, posttraumatic growth, and social connectedness in psilocybin-assisted group therapy: an interpretive phenomenological analysis","volume":"64","author":"Agin-Liebes","year":"2021","journal-title":"J Humanist Psychol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0269881117731279","article-title":"Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors","volume":"32","author":"Griffiths","year":"2018","journal-title":"J Psychopharmacol"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1515\/9781438433950","volume-title":"Holotropic Breathwork: a New Approach to Self-Exploration and Therapy","author":"Grof","year":"2010"},{"key":"ref19","volume-title":"Group Therapy for Cancer Patients: a Research-Based Handbook of Psychosocial Care","author":"Spiegel","year":"2000"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/00207284.1978.11491609","article-title":"A support group for dying patients","volume":"28","author":"Spiegel","year":"1978","journal-title":"Int J Group Psychother"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/00207284.1983.11491344","article-title":"Effects of group confrontation with death and dying","volume":"33","author":"Spiegel","year":"1983","journal-title":"Int J Group Psychother"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/00207284.1998.11491538","article-title":"The rationale and foundations of group psychotherapy for women with metastatic breast cancer","volume":"48","author":"Leszca","year":"1998","journal-title":"Int J Group Psychother"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1001\/archpsyc.58.5.494","article-title":"Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial","volume":"58","author":"Classen","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/02791072.2019.1593559","article-title":"Psychedelic-assisted group therapy: a systematic review","volume":"51","author":"Trope","year":"2019","journal-title":"J Psychoactive Drugs"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1001\/jamaoncol.2023.0351","article-title":"Thambi P assessment of psilocybin therapy for patients with Cancer and major depression disorder","volume":"9","author":"Agrawal","year":"2023","journal-title":"JAMA Oncology"},{"key":"ref26","author":"Dames","year":"2018"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fpsyt.2021.803279","article-title":"A cohort-based case report: the impact of ketamine-assisted therapy embedded in a community of practice framework for healthcare providers with PTSD and depression","volume":"12","author":"Dames","year":"2022","journal-title":"Front Psych"},{"key":"ref28","volume-title":"Root Strength: a Health and Care Professionals\u2019 Guide to Minimizing Stress and Maximizing Thriving","author":"Dames","year":"2022"},{"key":"ref29","volume-title":"Protocol MAPP1 Amendment 4 Version 1. [Protocol synopsis on the Internet]","year":"2020"},{"key":"ref30","first-page":"151","article-title":"Focusing-oriented psychotherapy as a supplement to preparation for psychedelic therapy","volume":"41","author":"Danforth","year":"2009","journal-title":"J Transpers Psychol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10484-015-9279-8","article-title":"Self-regulation of breathing as a primary treatment for anxiety","volume":"40","author":"Jerath","year":"2015","journal-title":"Appl Psychophysiol Biofeedback"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J Psychopharmacol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.explore.2016.08.001","article-title":"A systematic review and meta-analysis of randomized and nonrandomized trials of clinical emotional freedom techniques (EFT) for the treatment of depression","volume":"12","author":"Nelms","year":"2016","journal-title":"Explore"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1177\/0022167817715966","article-title":"Cancer at the dinner table: experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related existential distress","volume":"57","author":"Swift","year":"2017","journal-title":"J Humanist Psychol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/EDBK_279767","article-title":"Bringing life to death: the need for honest, compassionate, and effective end-of-life conversations","volume":"40","author":"MacKenzie","year":"2020","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"100042","DOI":"10.1016\/j.ssmmh.2021.100042","article-title":"The social route to mental health: a systematic review and synthesis of theories linking social relationships to mental health to inform interventions","volume":"1","author":"Andersen","year":"2021","journal-title":"SSM Mental Health"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1177\/0269881116677852","article-title":"Set and setting, psychedelics and the placebo response: an extra-pharmacological perspective on psychopharmacology","volume":"30","author":"Hartogsohn","year":"2016","journal-title":"J Psychopharmacol"},{"key":"ref38","author":"Slavin-Mulford","year":"2016"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1089\/psymed.2023.0004","article-title":"Psychedelic-assisted therapy training: Firsthand experience of non-ordinary states of consciousness in the development of competence","author":"Dames","year":"2024","journal-title":"Psychedelic Medicine"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1767215\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T04:20:37Z","timestamp":1784521237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1767215\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":39,"alternative-id":["10.3389\/fpubh.2026.1767215"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1767215","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"article-number":"1767215"}}